195 related articles for article (PubMed ID: 35014681)
1. Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies.
Bakker EY; Fujii M; Krstic-Demonacos M; Demonacos C; Alhammad R
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35014681
[TBL] [Abstract][Full Text] [Related]
2. Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state.
Alhammad R; Khunchai S; Tongmuang N; Limjindaporn T; Yenchitsomanus PT; Mutti L; Krstic-Demonacos M; Demonacos C
Oncol Rep; 2020 Dec; 44(6):2406-2418. PubMed ID: 33125139
[TBL] [Abstract][Full Text] [Related]
3. Subverted regulation of Nox1 NADPH oxidase-dependent oxidant generation by protein disulfide isomerase A1 in colon carcinoma cells with overactivated KRas.
De Bessa TC; Pagano A; Moretti AIS; Oliveira PVS; Mendonça SA; Kovacic H; Laurindo FRM
Cell Death Dis; 2019 Feb; 10(2):143. PubMed ID: 30760703
[TBL] [Abstract][Full Text] [Related]
4. Redox Regulation of Mitochondrial Fission Protein Drp1 by Protein Disulfide Isomerase Limits Endothelial Senescence.
Kim YM; Youn SW; Sudhahar V; Das A; Chandhri R; Cuervo Grajal H; Kweon J; Leanhart S; He L; Toth PT; Kitajewski J; Rehman J; Yoon Y; Cho J; Fukai T; Ushio-Fukai M
Cell Rep; 2018 Jun; 23(12):3565-3578. PubMed ID: 29924999
[TBL] [Abstract][Full Text] [Related]
5. Assessing the contribution of the two protein disulfide isomerases PDIA1 and PDIA3 to cisplatin resistance.
Kullmann M; Kalayda GV; Hellwig M; Kotz S; Hilger RA; Metzger S; Jaehde U
J Inorg Biochem; 2015 Dec; 153():247-252. PubMed ID: 26364260
[TBL] [Abstract][Full Text] [Related]
6. PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity.
Jang I; Pottekat A; Poothong J; Yong J; Lagunas-Acosta J; Charbono A; Chen Z; Scheuner DL; Liu M; Itkin-Ansari P; Arvan P; Kaufman RJ
Elife; 2019 Jun; 8():. PubMed ID: 31184304
[TBL] [Abstract][Full Text] [Related]
7. Expression of membrane protein disulphide isomerase A1 (PDIA1) disrupt a reducing microenvironment in endometrial epithelium for embryo implantation.
Fernando SR; Lee CL; Wong BP; Cheng KW; Lee YL; Chan MC; Ng EH; Yeung WS; Lee KF
Exp Cell Res; 2021 Aug; 405(2):112665. PubMed ID: 34111473
[TBL] [Abstract][Full Text] [Related]
8. Role of the ERO1-PDI interaction in oxidative protein folding and disease.
Shergalis AG; Hu S; Bankhead A; Neamati N
Pharmacol Ther; 2020 Jun; 210():107525. PubMed ID: 32201313
[TBL] [Abstract][Full Text] [Related]
9. Protein disulfide isomerase externalization in endothelial cells follows classical and unconventional routes.
Araujo TLS; Zeidler JD; Oliveira PVS; Dias MH; Armelin HA; Laurindo FRM
Free Radic Biol Med; 2017 Feb; 103():199-208. PubMed ID: 28034831
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic study of PDIA1-catalyzed TFF3 dimerization during sepsis.
Shi Y; Wang C; Wu D; Zhu Y; Wang ZE; Peng X
Life Sci; 2020 Aug; 255():117841. PubMed ID: 32454156
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Influence of Zinc Ions on the Conformational Stability and Activity of Protein Disulfide Isomerase.
Moretti AIS; Baksheeva VE; Roman AY; De Bessa TC; Devred F; Kovacic H; Tsvetkov PO
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396772
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an A-Site Selective Protein Disulfide Isomerase A1 Inhibitor.
Cole KS; Grandjean JMD; Chen K; Witt CH; O'Day J; Shoulders MD; Wiseman RL; Weerapana E
Biochemistry; 2018 Apr; 57(13):2035-2043. PubMed ID: 29521097
[TBL] [Abstract][Full Text] [Related]
13. Protein disulfide isomerases: Redox connections in and out of the endoplasmic reticulum.
Soares Moretti AI; Martins Laurindo FR
Arch Biochem Biophys; 2017 Mar; 617():106-119. PubMed ID: 27889386
[TBL] [Abstract][Full Text] [Related]
14. A molecular dynamics approach on the Y393C variant of protein disulfide isomerase A1.
Madero-Ayala PA; Mares-Alejandre RE; Ramos-Ibarra MA
Chem Biol Drug Des; 2020 Dec; 96(6):1341-1347. PubMed ID: 32352225
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into the dimerization of human protein disulfide isomerase.
Bastos-Aristizabal S; Kozlov G; Gehring K
Protein Sci; 2014 May; 23(5):618-26. PubMed ID: 24549644
[TBL] [Abstract][Full Text] [Related]
16. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
17. EF24 prevents rotenone-induced estrogenic status alteration in breast cancer.
Roy D; Kabiraj P; Pal R
Cell Biol Int; 2014 Apr; 38(4):511-9. PubMed ID: 24375813
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
20. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
